01408nam 2200337z- 450 991068947100332120161209100104.0(CKB)5860000000018090(BIP)007972804(EXLCZ)99586000000001809020220406c2001uuuu -u- -engAre the financial records of the federal government reliable? hearing before the Subcommittee on Government Management, Information, and Technology of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, March 31, 20001 online resource (iii, 45 p.) ill0-16-064909-9 Are the Financial Records of the Federal Government ReliableExecutive departmentsUnited StatesAuditingAdministrative agenciesUnited StatesAuditingFinancial statements, ConsolidatedUnited StatesExecutive departmentsAdministrative agenciesFinancial statementsPolitical scienceBusiness & economicsExecutive departmentsAuditing.Administrative agenciesAuditing.Financial statements, ConsolidatedBOOK9910689471003321Are the financial records of the federal government reliable3205971UNINA02976nam 2200865z- 450 991059507240332120230220(CKB)5680000000080802(oapen)https://directory.doabooks.org/handle/20.500.12854/92146(oapen)doab97463(EXLCZ)99568000000008080220202209d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNew Insights into the Pathogenesis and Therapies of IgA NephropathyBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (194 p.)3-0365-5041-0 3-0365-5042-9 IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and a frequent cause of kidney failure. Better understanding of the pathogenesis of IgAN and the related genetic, immunological, and cellular susceptibility factors are needed to enable the development of effective disease-specific therapy. This book brings together international experts to provide clinical and experimental studies and reviews with an emphasis on early diagnosis, prognosis, disease pathogenesis, determination of disease activity, and new strategies for treatment for IgAN.Medicine and Nursingbicsscaberrantly glycosylated IgA1adultsautoantibodybiomarkerbody mass indexCD38childrenclinical trialscomplementcomplement C3crescentsgalactose-deficient IgA1geneticsglomerular filtration rateglycosylation of IgA1IgAIgA nephropathyIgA NephropathyIgA vasculitisIgA VasculitisIgA1immune complexkidneykidney biopsykidney mesangiumKM55mesangial matrix expansionmouse modeln/anephritisnephrologyO-glycosylationobesityOxford scorephysiopathologyplasma cellspresentationprognosisproteinuriarenal pathologytreatmenturinary galactose-deficient IgA1Medicine and NursingSuzuki Hitoshiedt921974Novak JanedtSuzuki HitoshiothNovak JanothBOOK9910595072403321New Insights into the Pathogenesis and Therapies of IgA Nephropathy3039264UNINA